APLM (Apollomics Corp) Kacepetan wutah bathi saben saham ing taun lumaku
Apollomics, Inc. (APLM) focus on regulatory drug approval amid fierce competition has triggered a spike in the YoY earnings per share growth rate, which currently stands at 0.00. This chart confirms the success of the targeted therapy strategy for the US and Chinese markets. The development of personalized treatment protocols for lung and liver cancer ensures the company's long-term sustainability.
Rincian analitis lan laporan data perusahaan apollomicsinc.com (APLM)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- indikator beban utang lan likuiditas:
Utang marang Modal Apollomics, Inc.|APLM - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Apollomics|APLM - Utang perusahaan|Rasio utang marang kapitalisasi buku Apollomics, Inc.|APLM - Utang jangka dawa perusahaan|Utang jangka cendhak Apollomics|Indikator likuiditas cepet apollomicsinc.com
- rincian bathi lan kelipatan pasar:
APLM - Bathi resik|Prakiraan bathi perusahaan Apollomics, Inc.|APLM - Pangali P/E|Prakiraan rega marang bathi Apollomics|APLM - Rasio rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Apollomics, Inc.|APLM - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Apollomics|APLM - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan apollomicsinc.com|APLM - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Apollomics, Inc.
Analisis dhasar perusahaan:Apollomics Corp, APLM
This metric reflects the year-over-year dynamics of earnings per share. Comparing the annual EPS growth allows for an assessment of cash flow generation efficiency and capital density. The metric is sensitive to debt load, which is critical for analyzing the issuer's liquidity. For Apollomics, Inc. (APLM), this indicator demonstrates financial stability during the commercialization of oncology drugs. EPS growth will confirm the success of the expansion of targeted therapies in the US and Asian markets.
Pesaing utama
BeiGene Ltd. - Tambahing bathi saben saham ing taun lumaku|HALO (Halozyme Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Revolution Medicines Corp RVMD|Wutah bathi ing taun lumaku AAPG|Wutah bathi ing taun lumaku cgoncology.com (CGON)|Wutah bathi saben saham ing taun lumaku UroGen Pharma URGN|BCAX (Bicara Therapeutics Inc) - Dinamika bathi saben saham ing taun lumaku|PSNL - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Erasca Oncology|Delcath Systems, Inc. (DCTH) - Wutah bathi saben saham ing taun lumaku|YMAB (ymabs.com) - Wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Aura Biosciences|Wutah bathi saben saham ing taun lumaku CADL|Wutah bathi saben saham ing taun lumaku Accuray Inc. (ARAY)|SLS - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Actuate Therapeutics, Inc. ACTU|CTOR - Wutah bathi resik saben saham ing taun iki|TuHURA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Protara Therapeutics Inc TARA|FATE: Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki Aadi Bioscience|Wutah bathi saben saham ing taun lumaku TScan Therapeutics Inc|Champions Oncology Corp (CSBR) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben saham ing taun iki XBIT (XBiotech Inc.)|CVM (cel-sci.com) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku OSTX (OS Therapies Inc)|Prakiraan wutah bathi resik saben saham ing taun iki radiopharmtheranostics.com (RADX)|ARTV - Wutah bathi saben saham ing taun lumaku|ANL (Adlai Nortye Ltd.) - Wutah bathi saben saham ing taun iki|VERU: Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki Tempest Therapeutics Inc|Wutah bathi resik saben saham ing taun iki XLO|Enochian BioSciences (RENB) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku MURA|Wutah bathi ing taun lumaku kairospharma.com (KAPA)|Wutah bathi saben saham ing taun lumaku OnKure Therapeutics OKUR|GDTC (CytoMed Therapeutics Ltd) - Dinamika bathi saben saham ing taun lumaku|CRIS - Wutah bathi saben saham ing taun lumaku|THAR: Wutah bathi saben saham ing taun lumaku|advanbiomed.com (ADVB) - Wutah bathi saben saham ing taun lumaku|Wutah bathi resik saben saham ing taun iki genprex.com|CLDI (Calidi Biotherapeutics Inc.) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki sunshinebiopharma.com (SBFM)|Wutah bathi ing taun lumaku XBIO|Wutah bathi ing taun lumaku Salarius Pharma (SLRX)|Wutah bathi saben saham ing taun lumaku Purple Biotech PPBT|AONC: Wutah bathi saben saham ing taun iki|BeiGene - Wutah bathi ing taun lumaku|Checkpoint Therapeutics Inc. (CKPT) - Wutah bathi resik saben saham ing taun iki|ELEV: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku iCAD (ICAD)|Wutah bathi saben saham ing taun lumaku Ikena Oncology Inc.|NTBL: Tambahing bathi saben saham ing taun lumaku|Wutah bathi resik saben saham ing taun iki VIRX (Viracta Therapeutics)|MOR (MorphoSys Inc) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku NAYA (NAYA Bio)|AAPGV - Wutah bathi resik saben saham ing taun iki
